PF-Atlas › Drugs › N-acetylcysteine

N-acetylcysteine

Idiopathic Pulmonary Fibrosis

Clinical trials

Developer

Duke University

Overview

N-acetylcysteine is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 4 tracked IPF clinical trials.

N-acetylcysteine clinical trials

NCT00650091 (Phase 3)NCT04155632 (Phase 2)NCT02088216 (Not specified)NCT03956888 (Phase 3)

Explore related

All trials Research

Medical disclaimer. This page summarizes research about N-acetylcysteine for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.